Healthcare Realty Trust Incorporated $HR Shares Bought by Renaissance Technologies LLC

Renaissance Technologies LLC raised its holdings in shares of Healthcare Realty Trust Incorporated (NYSE:HRFree Report) by 100.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,549,172 shares of the real estate investment trust’s stock after buying an additional 774,500 shares during the quarter. Renaissance Technologies LLC’s holdings in Healthcare Realty Trust were worth $26,320,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of HR. PGGM Investments purchased a new position in shares of Healthcare Realty Trust in the fourth quarter worth about $113,389,000. Invesco Ltd. grew its stake in Healthcare Realty Trust by 233.8% during the 3rd quarter. Invesco Ltd. now owns 7,700,760 shares of the real estate investment trust’s stock valued at $138,845,000 after acquiring an additional 5,393,651 shares in the last quarter. Norges Bank purchased a new stake in Healthcare Realty Trust during the 4th quarter valued at about $62,154,000. Jupiter Asset Management Ltd. acquired a new stake in Healthcare Realty Trust in the 4th quarter valued at about $31,810,000. Finally, Rush Island Management LP lifted its stake in Healthcare Realty Trust by 13.8% in the 2nd quarter. Rush Island Management LP now owns 14,260,152 shares of the real estate investment trust’s stock worth $226,166,000 after purchasing an additional 1,728,491 shares in the last quarter.

Healthcare Realty Trust Stock Performance

HR opened at $21.77 on Thursday. The stock has a market capitalization of $7.54 billion, a PE ratio of -37.53 and a beta of 0.98. Healthcare Realty Trust Incorporated has a one year low of $15.28 and a one year high of $22.04. The business’s 50 day moving average price is $20.52 and its 200 day moving average price is $18.90.

Healthcare Realty Trust (NYSE:HRGet Free Report) last posted its earnings results on Thursday, April 30th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.02. Healthcare Realty Trust had a negative return on equity of 4.29% and a negative net margin of 17.34%.The company had revenue of $275.28 million during the quarter, compared to analysts’ expectations of $283.01 million. During the same quarter last year, the firm earned $0.39 earnings per share. The firm’s quarterly revenue was down 7.7% compared to the same quarter last year. As a group, equities research analysts forecast that Healthcare Realty Trust Incorporated will post 1.63 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on HR. BTIG Research restated a “buy” rating and set a $22.00 target price on shares of Healthcare Realty Trust in a report on Friday, June 12th. Scotiabank lifted their price objective on Healthcare Realty Trust from $20.00 to $22.00 and gave the stock an “outperform” rating in a research report on Friday, May 8th. Wells Fargo & Company boosted their price objective on Healthcare Realty Trust from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Monday, June 1st. JPMorgan Chase & Co. upped their target price on Healthcare Realty Trust from $19.00 to $21.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. Finally, Royal Bank Of Canada raised their target price on Healthcare Realty Trust from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Thursday, May 14th. Four analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $21.67.

Get Our Latest Analysis on Healthcare Realty Trust

Insider Activity at Healthcare Realty Trust

In other news, CAO Amanda L. Callaway sold 25,767 shares of the stock in a transaction on Tuesday, June 23rd. The stock was sold at an average price of $20.37, for a total transaction of $524,873.79. Following the completion of the transaction, the chief accounting officer directly owned 109,954 shares in the company, valued at approximately $2,239,762.98. This represents a 18.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.56% of the stock is currently owned by company insiders.

Healthcare Realty Trust Profile

(Free Report)

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.

See Also

Want to see what other hedge funds are holding HR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Realty Trust Incorporated (NYSE:HRFree Report).

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.